Abstract
Purpose To describe the visual and systemic outcomes in patients presenting with sarcoid uveitis.
Methods Seventy-five patients with definite or presumed sarcoid uveitis were followed up for a median of 4 years. The patients came from a primary ophthalmic referral centre and a specialist uveitis centre. The prognostic value of demographic and clinical features at the onset of disease were studied. Baseline and outcome variables were analysed by survival analysis.
Results After 10 years, 54% of patients retained normal visual acuity and 4.6% had lost vision to less than 6/36 in both eyes. Fifty-one per cent required oral steroids for uveitis and a further 11% needed additional immunosuppressants. Twenty-one per cent of patients had undergone a surgical procedure. At the onset of uveitis the lung was the most common organ involved (35%). After 10 years follow-up disease spread to other organs in 13 patients (17%); in 8 of 13 patients this was the central nervous system. The only outcome associated with baseline variables was bilateral visual loss, which was more likely in those over 40 years at presentation (p = 0.004).
Conclusions The ocular prognosis of sarcoid uveitis is unrelated to the extent of disease at onset. Patients with extraocular disease fared no differently from those with isolated ocular disease. Patients with sarcoid uveitis are at risk of neurological involvement for at least 15 years.
Similar content being viewed by others
Article PDF
References
Rothova A, Suttorp-van Schulten MSA, Treffers WF, Kijlstra A . Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332–6.
Karma A, Huhti E, Poukkula A . Course and outcome of ocular sarcoidosis. Am J Ophthalmol 1988;106:467–72.
Kaye GB, Salmon JF, Isaacs S . Risk factors for uveitis in sarcoidosis. South Afr Med J 1993;83:342–4.
Jabs DA, Johns CJ . Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986;102:297–301.
Iwai K, Tachibana T, Hosoda Y, Matsui Y . Sarcoidosis autopsies in Japan. Sarcoidosis 1988;5:60–5.
Hagerstrand I, Linell F . The prevalence of sarcoidosis autopsy material from a Swedish town. Acta Med Scand 1964;(Suppl 425):171–4.
Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJJ, Linssen A, Alberts C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992;76:137–41.
Tran VT, Auer C, Guex-Crosier Y, Pettet N, Herbort CP . Epidemiology of uveitis in Switzerland. Ocular Immunol Inflamm 1994;2:169–76.
Paivonsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J, Saari KM . Uveitis survey at the University Eye Clinic in Turku. Acta Ophthalmol 1994;72:505–12.
Nordentoft V, Møller PM . Mediastinoscopy with lymph node biospy carried out in patients with endogenous uveitis of unknown aetiology. Acta Ophthalmol 1970;48:331–43.
Ohara K, Okubo A, Kamata K, Sasaki H, Kobayashi J, Kitamura S . Transbronchial lung biopsy in the diagnosis of suspected ocular sarcoidosis. Arch Ophthalmol 1993;111:642–4.
Weinreb RN, Kimura SJ . Uveitis associated with sarcoidosis and angiotensin converting enzymes. Am J Ophthalmol 1980;89:180–5.
Baarsma GS, La Hey E, Glasius E, de Vries J, Kijlstra A . The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol 1987;104:211–7.
Stavrou P, Linton S, Young DW, Murray PL Clinical diagnosis of ocular sarcoid. Eye 1997;11:365–70.
Darva M-R, Merayo-Lloves J, Schaumberg, DA., Foster CS . Prognosticates for visual outcome in sarcoid uveitis. Ophthalmology 1996;103:1846–53.
Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, et al. Neurosarcoidosis. signs, course and treatment in 35 confrimed. cases. Medicine 1990;69:261–76.
Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994;149:893–8.
Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebart AC . Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989;72:287–96.
James DG, Friedman AI, Graham E . Uveitis: a series of 368 patients. Trans Ophthalmol Soc UK 1976;96:108–12.
James DG, Sharma OP . Neurosarcoidosis. Proc R Soc Med 1967;60:1169–70.
Manz HJ . Pathobiology of neurosarcoidosis and clinicopathological correlations. Can J Neurol Sci 1983;10:50–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edelsten, C., Pearson, A., Joynes, E. et al. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye 13, 748–753 (1999). https://doi.org/10.1038/eye.1999.221
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.221
Keywords
This article is cited by
-
Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population
Eye (2022)
-
Clinical features of ocular sarcoidosis: severe, refractory, and prolonged inflammation
Japanese Journal of Ophthalmology (2022)
-
Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis
Graefe's Archive for Clinical and Experimental Ophthalmology (2019)
-
Ethnicity and association with ocular, systemic manifestations and prognosis in 194 patients with sarcoid uveitis
Graefe's Archive for Clinical and Experimental Ophthalmology (2019)
-
Nonpulmonary manifestations of sarcoidosis
Current Rheumatology Reports (2002)